This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia
BMC Pediatrics Open Access 27 February 2021
-
Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia
Stem Cell Research & Therapy Open Access 13 February 2020
-
Mesenchymal stem cells show functional defect and decreased anti-cancer effect after exposure to chemotherapeutic drugs
Journal of Biomedical Science Open Access 19 January 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 1992; 79: 269–275.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
Ramasamy R, Tong CK, Seow HF, Vidyadaran S, Dazzi F . The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 2008; 251: 131–136.
Le Blanc K, Ringden O . Use of mesenchymal stem cells for the prevention of immune complications of hematopoietic stem cell transplantation. Haematologica 2005; 90: 438.
Fang B, Li N, Song Y, Li J, Zhao RC, Ma Y . Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia. Pediatr Transplant 2009; 13: 499–502.
Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007; 21: 1733–1738.
Campioni D, Rizzo R, Stignani M, Melchiorri L, Ferrari L, Moretti S et al. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytometry B Clin Cytom 2009; 76: 225–230.
Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841–846.
Acknowledgements
We thank Christopher Ridler for help with the animal experiments. These works were funded by Cancer Research UK and by European grant (contract No. LHSB-CT-2006-018817) to DB.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Jaganathan, B., Tisato, V., Vulliamy, T. et al. Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation. Leukemia 24, 1791–1795 (2010). https://doi.org/10.1038/leu.2010.164
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.164
This article is cited by
-
Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia
BMC Pediatrics (2021)
-
Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia
Stem Cell Research & Therapy (2020)
-
Mesenchymal stem cells show functional defect and decreased anti-cancer effect after exposure to chemotherapeutic drugs
Journal of Biomedical Science (2018)
-
K562 chronic myeloid leukemia cells modify osteogenic differentiation and gene expression of bone marrow stromal cells
Journal of Cell Communication and Signaling (2018)
-
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results
Bone Marrow Transplantation (2017)